HDAC9 and pulmonary fibrosis: The summarised data provides evidence that abnormally increased HDAC activity in lung fibroblasts and bronchiolar basal cells versus a lack of HDAC activity in AECII is critical in the pathogenesis of lung fibrosis, which can be overcome by treatment with HDAC inhibitors.